Guillain-Barré and Myasthenia Gravis Overview
45 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What symptom is NOT typically associated with Guillain-Barré syndrome?

  • Severe fever (correct)
  • Upward progression of motor weakness
  • Symmetric weakness
  • Diminished reflexes
  • Which laboratory test finding is characteristic of Guillain-Barré syndrome?

  • Elevated protein levels in CSF with normal cell count (correct)
  • Elevated creatinine levels in serum
  • Increased white blood cell count in CSF
  • Decreased glucose levels in CSF
  • What is a critical aspect of medical management for a patient with Guillain-Barré syndrome?

  • Assessment of respiratory function and muscle strength (correct)
  • Monitoring for signs of neurological improvement only
  • Supportive care only
  • Immediate discharge planning
  • Which treatment option is used to directly affect the peripheral nerve myelin antibody level in Guillain-Barré syndrome?

    <p>Plasmapheresis and IVIG</p> Signup and view all the answers

    During which phase of Guillain-Barré syndrome is ongoing assessment for disease progression emphasized?

    <p>Acute phase</p> Signup and view all the answers

    What is the primary characteristic of a myasthenic crisis?

    <p>Severe generalized muscle weakness</p> Signup and view all the answers

    Which treatment option is not typically used for exacerbations of myasthenia gravis?

    <p>Antihistamines</p> Signup and view all the answers

    What is the purpose of plasmapheresis in the treatment of myasthenia gravis?

    <p>To temporarily reduce circulating antibodies</p> Signup and view all the answers

    Which surgical procedure can lead to clinical improvement in myasthenia gravis patients?

    <p>Thymectomy</p> Signup and view all the answers

    During outpatient care for myasthenia gravis, which of the following strategies is emphasized for medication management?

    <p>Delay in medication can lead to complications</p> Signup and view all the answers

    What common precipitating event can lead to a myasthenic crisis?

    <p>Respiratory infection</p> Signup and view all the answers

    Which symptoms might indicate a cholinergic crisis in a patient with myasthenia gravis?

    <p>Excessive salivation and sweating</p> Signup and view all the answers

    What is an important nursing care strategy regarding nutrition in patients with myasthenia gravis?

    <p>Meals coinciding with the peak effects of medication</p> Signup and view all the answers

    What is a potential life-threatening complication associated with rapidly progressive weakness?

    <p>Cardiac dysrhythmias</p> Signup and view all the answers

    Which condition is linked to an inability to swallow in patients with rapidly progressive weakness?

    <p>Imbalanced nutrition</p> Signup and view all the answers

    Which intervention directly addresses respiratory function in patients with impending respiratory failure?

    <p>Maintaining effective respirations</p> Signup and view all the answers

    How does paralysis affect a patient's verbal communication?

    <p>Leads to cranial nerve dysfunction</p> Signup and view all the answers

    What nursing intervention can help decrease a patient's fear and anxiety related to loss of control?

    <p>Providing reassurance and support</p> Signup and view all the answers

    Which of the following is an indicator of recovery in a patient with impaired verbal communication?

    <p>Demonstration of effective articulation</p> Signup and view all the answers

    What is a common complication that can occur alongside deep vein thrombosis in these patients?

    <p>Pulmonary embolism</p> Signup and view all the answers

    Which nursing outcome is associated with providing adequate nutrition to a patient with swallowing difficulties?

    <p>Improved energy levels</p> Signup and view all the answers

    What is the initial manifestation of myasthenia gravis in the majority of patients?

    <p>Weakness in ocular muscles</p> Signup and view all the answers

    Which symptom is often associated with weakness of the facial muscles in myasthenia gravis?

    <p>Bland facial expression</p> Signup and view all the answers

    What does the Tensilon test involve in diagnosing myasthenia gravis?

    <p>Administration of a fast-acting acetylcholinesterase inhibitor</p> Signup and view all the answers

    What is one of the risks associated with laryngeal involvement in myasthenia gravis?

    <p>Choking and aspiration</p> Signup and view all the answers

    Which of the following is used as a diagnostic test for myasthenia gravis alongside the Tensilon test?

    <p>Ice test</p> Signup and view all the answers

    What is the first line of pharmacologic therapy for myasthenia gravis?

    <p>Pyridostigmine bromide</p> Signup and view all the answers

    Which of the following statements about myasthenia gravis is true?

    <p>It has no effect on coordination.</p> Signup and view all the answers

    What is the goal of medical management for patients with myasthenia gravis?

    <p>Improve function and remove antibodies</p> Signup and view all the answers

    What is a common goal for patients with myasthenia gravis?

    <p>Promotion of speech and swallowing mechanisms</p> Signup and view all the answers

    Which of the following best describes myasthenia gravis?

    <p>An autoimmune disorder affecting muscle strength</p> Signup and view all the answers

    How does myasthenia gravis primarily affect muscle function?

    <p>By reducing the number of available receptors for stimulation</p> Signup and view all the answers

    What type of activities is encouraged for patients with myasthenia gravis?

    <p>Promoting physical activity within limits</p> Signup and view all the answers

    What is the primary cause of muscle weakness in patients with myasthenia gravis?

    <p>Antibodies blocking acetylcholine receptors</p> Signup and view all the answers

    What is a significant structural abnormality found in 75% of individuals with myasthenia gravis?

    <p>Thymic hyperplasia or tumor</p> Signup and view all the answers

    Which symptom is commonly not associated with myasthenia gravis?

    <p>Heightened muscle response to stimulation</p> Signup and view all the answers

    What should be included in the nursing interventions for a patient with myasthenia gravis?

    <p>Minimizing spasticity and contractures</p> Signup and view all the answers

    What is the most common form of dementia?

    <p>Alzheimer’s Disease</p> Signup and view all the answers

    Which of the following is NOT a risk factor for Alzheimer's Disease?

    <p>Regular exercise</p> Signup and view all the answers

    What are neurofibrillary tangles associated with?

    <p>Communication failure between neurons</p> Signup and view all the answers

    How often does someone in the US develop Alzheimer's Disease?

    <p>Every 66 seconds</p> Signup and view all the answers

    Which symptom is NOT commonly associated with severe stages of Alzheimer's Disease?

    <p>Hallucinations</p> Signup and view all the answers

    What typically begins to accumulate in the brains of individuals with Alzheimer's Disease?

    <p>Beta-amyloid plaques</p> Signup and view all the answers

    Which statement is true regarding Alzheimer's Disease?

    <p>It causes progressive memory loss.</p> Signup and view all the answers

    What brain region is most affected in Alzheimer's Disease?

    <p>Cerebral cortex</p> Signup and view all the answers

    Study Notes

    Neurological Autoimmune Disorders

    • Course: NURS3101 - Care of the Adult Population
    • Course location: University of Belize
    • Faculty: MS. Michelle Cox Hoare
    • Number of weeks: 13
    • Duration: 125 minutes

    Learning Objectives

    • Define Multiple Sclerosis (MS)
    • Describe the pathophysiology of MS and Myasthenia Gravis
    • Describe the clinical manifestations of MS and Myasthenia Gravis
    • Define Parkinson's and Alzheimer's disease
    • Describe the pathophysiology of Parkinson's and Alzheimer's disease
    • Describe medical and nursing management of neurological disorders (MS, Myasthenia Gravis, Guillain-Barré Syndrome, Parkinson's and Alzheimer's disease)
    • Apply the nursing process in the management of patients with these diseases

    What is Multiple Sclerosis (MS)?

    • Autoimmune condition where the immune system attacks the body's own tissues
    • Progressive demyelinating disease of the CNS
    • Demyelination is the destruction of myelin, impairing nerve impulse transmission
    • Cause is not definitively known but factors include genetics, immunology, and environment
    • No genetic transmission
    • Environmental risk factors include smoking, lack of vitamin D, and exposure to Epstein-Barr virus

    MS Pathophysiology

    • T cells enter the brain via disruption of the blood-brain barrier
    • T cells recognize myelin as foreign and attack it triggering an inflammatory process.
    • Inflammatory processes release cytokines and antibodies, stimulating macrophages to attack myelin.
    • B cells produce antibodies that mark the myelin for engulfment by macrophages
    • Macrophages engulf the myelin and oligodendrocytes
    • Without oligodendrocytes, there is no remyelination in the axons.
    • Immune attacks are intermittent and regulatory T cells are activated following each attack to control further immune cell activation.
    • Upon early attack, myelin repairs the axons, however, repeated attacks lead to irreversible damage.

    Clinical Manifestations of MS

    • Difficulty walking, speech problems (Dysarthria), blurry vision, balance problems, numbness or tingling, muscle stiffness or spasms
    • Other common symptoms are fatigue, cognitive impairment, bladder or bowel problems

    Assessment and Diagnostic Findings of MS

    • Diagnosis based on the presence of multiple plaques in the CNS observed with Magnetic Resonance Imaging (MRI)
    • Spinal tap (Lumbar puncture) to detect high levels of antibodies in cerebrospinal fluid (CSF)
    • Visual evoked potential to assess visual stimulus response
    • Neuropsychological testing to assess cognitive impairment

    Medical Management of MS

    • Management strategies aim at speeding recovery from attacks, slowing disease progression and managing symptoms
    • Medications: Immunomodulators, Corticosteroids (dexamethasone, methylprednisolone), immunosuppressants (methotrexate)
    • Disease-modifying therapies
    • Symptom management for specific complications

    Nursing Process for MS

    • Assess function at rest and when fatigued, including weakness, spasticity, visual impairment, incontinence, and swallowing/speech difficulties; how disease has affected lifestyle
    • Nursing Diagnoses: Impaired bed, physical mobility, risk for injury, impaired urinary and bowel elimination, impaired verbal communication, chronic confusion, ineffective individual coping

    Planning and Goals for MS

    • Goals include promotion of physical mobility, injury avoidance, achievement of bladder and bowel continence, promotion of speech and swallowing, improvement of cognitive function, development of coping skills, home maintenance, and adaptation to sexual dysfunction

    Nursing Interventions for MS

    • Promoting physical activity and exercise
    • Minimizing spasticity and contractures
    • Rest and proper nutrition

    Myasthenia Gravis

    • Autoimmune neuromuscular disorder affecting the myoneural junction
    • Characterized by variable degrees of voluntary muscle weakness
    • Primarily affecting the muscles of the eyes, face, and mouth

    Myasthenia Gravis Pathophysiology

    • Acetylcholine (ACh) attaches to the receptor sites on the motor end plate stimulating muscle contraction
    • Antibodies directed at the ACh receptor sites impair impulse transmission across the myoneural junction
    • Fewer ACh receptors become available, leading to muscle weakness that worsens with continued activity.
    • Thymic abnormalities, including hyperplasia or tumors, are common in patients with MG.

    Myasthenia Gravis Clinical Manifestations

    • Initial manifestation in 80% of patients involves ocular muscles (diplopia, ptosis - drooping eyelids)
    • Weakness of facial and throat muscles (bulbar), generalized weakness
    • Laryngeal involvement (dysphonia - voice impairment, dysphagia - difficulty swallowing), risk of choking and aspiration
    • Generalized weakness affecting extremities and intercostal muscles causing decreased vital capacity and respiratory failure

    Myasthenia Gravis Assessment and Diagnostic Findings

    • Physical examination, Tensilon test (edrophonium chloride), ice test
    • Tensilon test- IV administration of edrophonium chloride, a fast acting acetylcholinesterase inhibitor, a temporary improvement in muscle strength is indicative of MG.
    • Ice test- ice pack over eyes for one minute, temporary reversal of diplopia and ptosis, indicative of MG.
    • MRI assessment of the thymus gland.

    Myasthenia Gravis Medical Management

    • Improve function, reduce, and remove circulating antibodies
    • Therapeutic modalities include anticholinesterase medications (pyridostigmine bromide), immunosuppressive therapy, plasmapheresis, and thymectomy.

    Myasthenia Gravis Complications

    • Myasthenic crisis, an exacerbation of the disease characterized by severe generalized muscle weakness, jaw and tongue weakness, inability to swallow, difficulty with respirations as a result of respiratory and bulbar weakness.
    • Crisis results from disease exacerbation or a precipitating event (infection, stress, medication changes, surgery).

    Myasthenia Gravis Nursing Management

    • Outpatient self-care: medication management, energy conservation, strategies for ocular manifestations, and complication prevention.
    • Emphasize consequences of delaying medication, signs and symptoms of myasthenic and cholinergic crisis
    • During mealtime, administer anticholinesterase medication to coincide with peak effects to minimize aspiration risk.
    • Impaired vision from ptosis (drooping eyelid) or double vision management. Instill artificial tears, tape eyes as necessary.

    Guillain-Barré Syndrome

    • Autoimmune attack on the peripheral nerve myelin, resulting in acute, rapidly progressive ascending weakness
    • Often follows a viral infection, usually with a few weeks delay

    Guillain-Barré Syndrome Pathophysiology

    • Demyelination of peripheral nerves causing weakness, hyporeflexia, and paresthesia.
    • Damage to axons needs time to recover, a process that can take months or years to complete completely.
    • Infectious organism's amino acid mimics peripheral nerve myelin protein, and immune system mistakenly targets and destroys peripheral nerve myelin.

    Guillain-Barré Syndrome Clinical Manifestations

    • Muscle weakness and diminished reflexes of the lower extremities, sometimes ascending to tetraplegia.
    • Respiratory failure due to neuromuscular weakness of the diaphragm and intercostal muscles
    • Sensory symptoms like dysesthesia (pain, numbness) in the hands and feet
    • Cranial nerve demyelination may result in blindness or difficulty with swallowing or autonomic dysfunction

    Guillain-Barré Syndrome Assessment and Diagnostic Findings

    • Symmetric weakness, diminished reflexes, and upward progression of motor weakness
    • History of viral illness in few weeks preceding symptoms.
    • Assessment of vital capacity, negative inspiratory force
    • CSF analysis shows elevated protein levels without lymphocytic pleocytosis.

    Guillain-Barré Syndrome Medical Management

    • Intensive care unit monitoring and management of respiratory failure.
    • Respiratory therapy, mechanical ventilation, chest physiotherapy for secretion removal.
    • Plasmapheresis and IVIG to target peripheral nerve myelin antibody level.

    Guillain-Barré Syndrome Nursing Management

    • Monitor for impending respiratory failure, cardiac dysrhythmias, venous thromboembolism (VTE).
    • Maintain effective respirations, physical and mobility support, nutrition support, communication, and address patient fears by providing holistic care.

    Parkinson's Disease

    • Progressive neurologic disorder affecting movement, leading to disability.
    • Fourth most common neurodegenerative disease

    Parkinson's Disease Pathophysiology

    • Degeneration of dopamine storage cells in the substantia nigra.
    • Reduces dopamine levels in the corpus striatum
    • Imbalance of acetylcholine (excitatory) and dopamine (inhibitory) in striatal neurons impairs motor control and refinement

    Parkinson's Disease Clinical Manifestations

    • Tremor (resting tremor, usually unilateral), rigidity, bradykinesia, and postural instability
    • Difficulty with voluntary movements and postural reflexes

    Parkinson's Disease Assessment and Diagnostic Findings

    • Diagnosis is clinical. Symptoms include at least two of the cardinal manifestations: tremors, rigidity, bradykinesia, postural instability
    • No specific tests to diagnose PD
    • MRI to rule out other conditions

    Parkinson's Disease Medical Management

    • Treatment is directed toward controlling symptoms and maintaining functional independence
    • Pharmacologic management is mainstay: antiparkinsonian medications to increase striatal dopaminergic activity, reduce excitatory cholinergic activity, or affect other neurotransmitters.

    Parkinson's Disease Nursing Management

    • Assess how the disease affects ADLs and functional abilities: mobility, feeding, communication.
    • Assess cranial nerves, cerebellar function, and motor function.
    • Observe gait and activities
    • Assess speech clarity, space perception, depression, family supports and access to social services.

    Alzheimer's Disease

    • Chronic, irreversible brain disease, a type of dementia.
    • Most common form of dementia

    Alzheimer's Disease Pathophysiology

    • Degeneration of brain neurons, especially in the cerebral cortex.
    • Accumulation of neurofibrillary tangles and amyloid plaques.
    • Affects communication among neurons, resulting in memory loss, impaired thinking, disorientation, and personality changes.

    Alzheimer's Disease Clinical Manifestations

    • Memory loss, disorientation, impaired thinking, and personality changes
    • Begins gradually, but progressively worsens.

    Alzheimer's Disease Risk Factors

    • Age
    • Family history, genetic predisposition
    • Metabolic syndrome (diabetes, high blood pressure, high cholesterol), obesity
    • Smoking

    Alzheimer's Disease Assessment and Diagnostic Findings

    • Diagnosis is clinical, based on symptoms and ruling out other causes with patient history and physical exam
    • No definitive tests
    • Stages may vary

    Alzheimer's Disease Medical Management

    • Medications may improve some symptoms but cannot cure or stop progression.
    • Treatment is directed at managing symptoms and supporting functional independence.

    Alzheimer's Disease Nursing Management

    • Focus on maintaining client health, promote mental and social activities, physical activity, and nutrition support.
    • Assess patient's current ADLs and functional problems, communication, memory, gait and balance, safety considerations (medication and cognitive impairments), family support.
    • Non-pharmacological strategies include: communication and interaction strategies, therapeutic activities, environmental modifications to optimize safety and well-being.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Test your knowledge on Guillain-Barré syndrome and myasthenia gravis with this comprehensive quiz. Explore symptoms, laboratory findings, critical management aspects, and treatment options. Perfect for medical students and healthcare professionals alike.

    More Like This

    Use Quizgecko on...
    Browser
    Browser